What is Chase-Logeman?
Chase-Logeman Corporation stands as a premier manufacturer of precision filling machinery, distinguished by its specialized Monoblock-style equipment. Serving critical sectors including pharmaceuticals, diagnostics, healthcare, and industrial wellness, the company leverages over six decades of engineering expertise to deliver reliable, easy-to-validate solutions. Their product portfolio, which encompasses fully and semi-automatic filling, capping, labeling, and vial handling systems, is engineered for longevity and operational simplicity. By maintaining a rigorous commitment to quality, Chase-Logeman has solidified its reputation as a vital partner for enterprises seeking to optimize complex filling processes and ensure regulatory compliance in high-stakes production environments.
How much funding has Chase-Logeman raised?
Chase-Logeman has raised a total of $341K across 2 funding rounds:
Debt
$150K
Debt
$191K
Debt (2020): $150K with participation from PPP
Debt (2021): $191K led by PPP
Key Investors in Chase-Logeman
PPP
Public-Private Partnership
What's next for Chase-Logeman?
With the recent influx of capital, Chase-Logeman is positioned to accelerate its strategic initiatives, likely focusing on the modernization of its manufacturing facilities and the expansion of its automated product lines. As the company navigates the late-stage growth phase, the focus will shift toward integrating advanced digital monitoring capabilities into its existing machinery, thereby increasing the value proposition for its pharmaceutical and diagnostic clients. This strategic investment serves as a catalyst for further innovation, enabling the firm to maintain its competitive edge in an increasingly automated industrial landscape while exploring new market segments that require high-precision, validated filling solutions.
See full Chase-Logeman company page
